Geographically, Avidity Biosciences established its primary corporate headquarters and state-of-the-art research laboratories in San Diego, California, which is universally recognized as one of the world's premier biotechnology, pharmaceutical, and life sciences innovation hubs. This strategic location allowed the company to seamlessly attract elite scientific talent, collaborate with top-tier academic research institutions, and access massive pools of venture capital. In terms of its position within the broader biosciences industry, Avidity established itself as a groundbreaking pioneer and absolute leader in the development of antibody-oligonucleotide conjugates (AOCs). By successfully combining the immense precision and tissue-targeting capabilities of monoclonal antibodies with the therapeutic power of oligonucleotide genetic medicines, the company solved major historical drug delivery barriers, cementing its legacy as a top-tier innovator before its acquisition.